Fluticasone propionate and budesonide does not influence bone metabolism in the long term treatment of asthma

As a result, having no adverse effect on bone metabolism and adrenal function, in the regard to clinical efficacy, FP is as effective as the double dose of BUD on PEFR and FEV1.